SSY GROUP (02005.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec5

Stone Pharmaceutical Group Obtains Approval for Fingolimod Active Pharmaceutical Ingredient Registration

08:32

Dec4

SJM Pharmaceutical's Bilastine and Picosulfate Approved by China's NMPA

08:32

Nov28

Stone Pharmaceutical Obtains Production Registration for Tolterodine Tartrate Extended-Release Capsules

04:05

Nov27

Stone Pharmaceutical Group Obtains Approval for Palmitate Vitamin A Production and Sales

04:02

Nov26

Sino-Uncle Pharmaceutical Group and Stone Pharmaceutical Group Conducted Latest Shareholding Disclosure

00:05

Nov14

Stone Pharmaceutical Group Obtains Production Registration for Indobufen Tablets

04:13

Schedules & Filings

Schedules

Filings

Sep26

Distribution Plan(CST)

Cash dividend 0.05 HKD

Sep12

Distribution Plan(CST)

Cash dividend 0.05 HKD

Sep11

Distribution Plan(CST)

Cash dividend 0.05 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More